Su TH, et al. - This work is designed to investigate the patterns; predictors for virological relapse (VR), clinical relapse (CR), sustained clinical response (SCR); and retreatment outcomes after nucleos(t)ide analogue (NUC) therapy discontinuation. Based on findings, researchers conclude that an earlier relapse is related to tenofovir rather than entecavir discontinuation. NUC-specific post-therapy monitoring is recommended.